Hepatitis Drugs Market Size is estimated to grow at a CAGR of 25.0% during the forecast period
The global hepatitis drugs market is estimated to grow at a CAGR of 25.0% during the forecast period 2022-2030. One of the leading killers in the world is hepatitis, according to research. Hepatitis type B complications account for over 0.8 million annual deaths, and hepatitis type C is thought to be the cause of 0.5 million annual fatalities. Hepatitis is a serious inflammatory medical disorder that has a negative impact on the liver. The illness can also have major negative effects on a person's brain and digestive system. Acute, semi-acute, or chronic infection might result from it. Viral hepatitis, which can be brought on by any of the five hepatotropic viruses A, B, C, D, and E, is the most prevalent type of hepatitis. HAV, HBV, and HCV are the three most well-known kinds of hepatitis diseases. In addition to bacterial and viral infections, autoimmune illnesses, excessive alcohol use, toxins, and specific prescription drugs can also contribute to the cond...